Evidence map›Paper›PMID 33409441›Full record

ArticleJournal of vitreoretinal diseases2020

Quantifying Subclinical and Longitudinal Microvascular Changes Following Episcleral Plaque Brachytherapy Using Spectral Domain-Optical Coherence Tomography Angiography.

Kyle M Green, Brian C Toy, Bright S Ashimatey, Debarshi Mustafi, Richard L Jennelle, Melvin A Astrahan, Zhongdi Chu, Ruikang K Wang, Jonathan Kim, Jesse L Berry and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of vitreoretinal diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Radiation retinopathy: a review.International ophthalmology · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Kyle M GreenUSC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Brian C ToyUSC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Bright S AshimateyUSC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Debarshi MustafiUSC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Richard L JennelleDepartment of Radiation Oncology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA.
Melvin A AstrahanDepartment of Radiation Oncology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA.
Zhongdi ChuDepartment of Bioengineering, University of Washington, Seattle, Washington.
Ruikang K WangDepartment of Bioengineering, University of Washington, Seattle, Washington.
Jonathan KimUSC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Jesse L BerryUSC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Amir H KashaniUSC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
University of Southern California · USUniversity of Washington · US

Funding

Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel DiseaseUH3NS100614 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KASHANI, AMIR H, RINGMAN, JOHN M · 2018 to 2020
$4.3M
Assessment of Retinal Capillary Density, Morphology and Function in Retinal Vascular Disease Using Novel OCT Angiography Based MetricsR01EY030564 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KASHANI, AMIR H · 2019 to 2024
$3.5M
Ultra-wide field optical coherence tomography based angiography for imaging diabetic retinopathyR01EY028753 · NEI · UNIVERSITY OF WASHINGTON · PI WANG, RUIKANG · 2018 to 2021
$2.2M
Development of a surrogate liquid biopsy from the aqueous humor in retinoblastoma eyes.K08CA232344 · NCI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI BERRY, JESSE L · 2018 to 2022
$1.1M
Functional Imaging in Hypoxic-Ischemic Retinal DiseaseK08EY027006 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KASHANI, AMIR H · 2016 to 2020
$978k
NCI NIH HHS K08 CA232344NEI NIH HHS K08 EY027006NEI NIH HHS R01 EY028753NEI NIH HHS R01 EY030564NINDS NIH HHS UH3 NS100614
6 · The paper itself

Abstract

purposeTo assess longitudinal microvascular changes in eyes treated with I-125 episcleral plaque brachytherapy (EPB).

methodsHigh resolution OCT angiograms of the central 3×3mm macula were obtained from I-125 episcleral plaque brachytherapy treated and untreated fellow eyes of 61 patients. Capillary density (vessel skeleton density, VSD) and caliber (vessel diameter index, VDI) were quantified using previously validated semi-automated algorithms. Nonperfusion was also quantified as flow impairment regions (FIR). Exams from treated and fellow eyes obtained pre-treatment and at 6-month, 1-year, and 2-year intervals were compared using generalized estimating equation linear models. Dosimetry maps were used to evaluate spatial correlation between radiation dose and microvascular metrics.

resultsAt 6 months, treated eyes had significantly lower VSD (0.145 ± 0.003 vs 0.155 ± 0.002;

conclusionsOCTA can be used to quantify and monitor EPB induced retinopathy, and can detect vascular abnormalities even in the absence of clinically observable retinopathy. OCTA may therefore be useful in investigating treatment interventions that aim to delay EPB-induced radiation retinopathy.

Indexed as

BiomarkerCapillaryChoroidal MelanomaEpiscleral Plaque BrachytherapyOptical Coherence Tomography AngiographyRadiation Retinopathy

Identifiers

PMID33409441
PMCPMC7785061
OpenAlexW3049359041

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.